Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy (Q34617366)

3 August 2017

Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy (English)

1 reference

3 August 2017

1 reference

Jamshid Roozbeh

1

1 reference

3 August 2017

Mohammad Amin Banihashemi

2

1 reference

3 August 2017

Mohammad Ghezlou

3

1 reference

3 August 2017

Raha Afshariani

4

1 reference

3 August 2017

Soheila Salari

5

1 reference

3 August 2017

Maryam Moini

6

1 reference

3 August 2017

Mohammad Mahdi Sagheb

7

1 reference

3 August 2017

language of work or name

1 reference

1 January 2010

1 reference

3 August 2017

1 reference

3 August 2017

32

1 reference

3 August 2017

2

1 reference

3 August 2017

172-178

1 reference

The changing patterns of chronic kidney disease: the need to develop strategies for prevention relevant to different regions and countries.

3 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Diabetic complications and dysregulated innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

The role of protein traffic in the progression of renal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Understanding the nature of renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Multiple-dose pharmacokinetics of pentoxifylline and its metabolites during renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Angiotensin-converting enzyme inhibitors and type 2 diabetic nephropathy: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Angiotensin-converting enzyme inhibitors versus AT1 receptor antagonist in cardiovascular and renal protection: the case for AT1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860221003602645

10.3109/08860221003602645

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference